FindTrial
Sign In

Observe Similarities and Differences Between Hypertrophic Cardiomyopathy And Hridrog With the Help Of 2DEchocardiography

Comparative Assessment of Hypertrophic Cardiomyopathy with Hridrog Using 2D-Echocardiography - Nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065967
Enrollment
70
Registered
2024-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I422- Other hypertrophic cardiomyopathy Health Condition 2: I422- Other hypertrophic cardiomyopathy

Interventions

None listed

Sponsors

Dr Devendra Sancheti
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patientâ??s age group above 18 yrs 2.Patients having symptoms of Hypertrophic cardiomyopathy along with other symptoms of Hridrog. 3.Hypertrophic cardiomyopathy diagnosed with 2DEchocardiography will be taken

Exclusion criteria

Exclusion criteria: 1.Congestive cardiac failure, Congenital abnormalities (ASD, VSD), Valvular Heart Disease. 2.Any other illness like DM, DI, Hypo or Hyperthyroidism, Renal disorders, respiratory disorders like COPD.

Design outcomes

Primary

MeasureTime frame
To Compare Hypertrophic cardiomyopathy with hridrog with special reference to 2D-EchocardiographyTimepoint: 9 Weeks—

Secondary

MeasureTime frame
1.To Observe the similarities in enteropathogenesis of Hypertrophic Cardiomyopathy & hridrog 2.To observe the ECG changes seen in Patients of Hypertrophic CardiomyopathyTimepoint: 60 days—

Countries

India

Contacts

Public ContactDr Prakash Mane

Dr D Y Patil College of Ayurved and Research center

maneprakash1171@gmail.com9423277615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026